Clinical Trial Update: Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial updates explore eltrombopag for thrombocytopenia after consolidation therapy in acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Eltrombopag, Thrombocytopenia | Phase 2, Phase 3 | Status: UNKNOWN